tr=da[,1] A=da[tr=="A",2];B=da[tr=="B",2];D=da[tr=="AB",2] #SFs n1=length(A);n2=length(B);n3=length(D) #n lA=log(A);lB=log(B);lD=log(D) #log(SF) y1=mean(lA);y2=mean(lB);y3=mean(lD) s1=var(lA)*(n1-1);s2=var(lB)*(n2-1);s3=var(lD)*(n3-1) sy=s1+s2+s3 # total suam of squares dft=n1+n2+n3-3;denf=1/n1+1/n2+1/n3 #df tss=(y1+y2-y3)/sqrt(sum(sy)/dft)/denf # t-test statistic pv=2*(1-pt(abs(tss),df=dft)) # p-value for Bliss independence hypothesis pvP=1-pt(tss,df=dft) # One-sided p-value print("Testing for Bliss independence:") print(paste("T-stat=",round(tss,3),", y1+y2-y3=",round(y1+y2-y3,3), ", exp(y1+y2-y3)=",round(exp(y1+y2-y3),3),", p-value=",round(pv,3),sep="")) # Box plot m=matrix(ncol=3,nrow=4) m[1:3,1]=lA;m[,2]=lB;m[,3]=lD indep=rep(0,n1*n2) k=0 for(i1 in 1:n1) for(i2 in 1:n2){ k=k+1 indep[k]=m[i1,1]+m[i2,2] } par(mfrow=c(1,1),mar=c(4,4,1,1)) yl=c (.3,.4,.5,.6,.7,.8,.9 ) # tickmarks for the original SF lyl=log(yl) # log tickmarks boxplot (list(lA,lB,lD,indep) ,names=namgr,xlab="",ylab="",ylim=range(lyl),axes=F) mtext(side=1,"Treatment groups",cex=1.25,line=2.75) mtext(side=2,"Surviving fraction, %",cex=1.25,line=2.5) axis(side=2,at=lyl,as.character(yl*100)) axis(side=1,at=1:4,namgr) lines (x=c(3,3,4,4) ,y=c(log(.55),log(.6),log(.6),log(.55)),lwd=3) text(3.5,log(.64),paste("P-value =",round(pv,3)),font=2) yn=log (c(70,50,32,36 .5)/100) text(1:4,yn,paste("n=",c(n1,n2,n3,n1*n2),sep=""),cex=1.25) } The call daphnia(dr="d") produces the folowing output (the data file Daphnia.csv must be saved in the folder specified by the read.csv command) and Figure 2 :
 daphnia(dr="d")
[1] "Testing for Bliss independence:"
[1] "T-stat=1.499, y1+y2-y3=0.156, exp(y1+y2-y3)=1.168, p-value=0.172"
Treatment interaction in the presence of control group
The *.csv data file has the same format but contains information on the control group (C). The screen snapshot for the data from example on testing the synergy for cancer cells is shown below.
The R code is similar to daphnia listed above. bc.control=function(dr="c") { #ZR75 cancer line cells da=read.csv(paste(dr,":\\Projects\\ToddMiller\\Synergy\\ZR75.csv",sep="")) namgr=c("BYL","GSK","BYL & GSK","Independence") tr=da[,1] C=da[tr=="C",2];A=da[tr=="A",2];B=da[tr=="B",2];D=da[tr=="AB",2] #SFs n0=length(C);n1=length(A);n2=length(B);n3=length(D) #n lC=log(C);lA=log(A);lB=log(B);lD=log(D) y0=mean(lC);y1=mean(lA);y2=mean(lB);y3=mean(lD) s0=var(lC)*(n0-1);s1=var(lA)*(n1-1);s2=var(lB)*(n2-1);s3=var(lD)*(n3-1) sy=s0+s1+s2+s3 dft=n0+n1+n2+n3-4;denf=1/n0+1/n1+1/n2+1/n3 tss=(y1+y2-y3-y0)/sqrt(sum(sy)/dft)/denf pv=2*(1-pt(abs(tss),df=dft)) pvP=1-pt(tss,df=dft) # one-sided p-value print("Testing for Bliss independence in the presence of the control group:") print(paste("T-stat=",round(tss,3),", y1+y2-y3-y0=",round(y1+y2-y3,3)," , exp(y1+y2-y3-y0)=",round(exp(y1+y2-y3-y0),3),", p-value=",round(pv,3),sep="")) print(c(sy,dft,denf,tss)) m=cbind (lC,lA,lB,lD) indep=rep(0,n1*n2*n3) k=0 for(i1 in 1:n1) for(i2 in 1:n2)
} par(mfrow=c(1,1),mar=c(4,4,1,1)) yl=c(.1,.2,.4,.7,1);lyl=log(yl) boxplot(list(lCA,lCB,lCD,indep),names=namgr,xlab="",ylab="",ylim=range(lyl),axes=F) mtext(side=1,"Treatment groups",cex=1.25,line=2.75) mtext(side=2,"Surviving fraction from control, %",cex=1.25,line=2.5) axis(side=2,at=lyl,as.character(yl*100)) axis(side=1,at=1:4,namgr) lines (x=c(3,3,4,4) ,y=c(log(.7),log(.8),log(.8),log(.7)),lwd=3) text(3.5,log(.88),paste("P-value =",round(pv,3)),font=2) yn=log(c(60,27,12,18)/100) text(1:4,yn,paste("n=",c(n1*n0,n2*n0,n3*n0,n0*n1*n2),sep=""),cex=1.25) }
The call for the example using ZR75 treatment data is listed below (it produces Figure 3 ):  bc.control(dr="d") [1] "Testing for Bliss independence in the presence of the control group:" [1] "T-stat=1.691, y1+y2-y3-y0=0.494, exp(y1+y2-y3-y0)=1.653, p-value=0.129"
Tumor growth experiments in vivo
The tumor growth data in each group is estimated by linear mixed model with random intercept (mice-specific baseline tumor volume) using function lme from the library nlme, as discussed in detail in Demidenko (2013) . The following R code plots Figure 6 , estimates the rate of slope (beta coefficients) and the one-sided -value for synergy. Tumor volume is plotted on the log scale with th etickmarks on the original mm 3 scale. Before calling the tum.growth function the data file (provided) MCF-7_April_2016.csv must be saved in the folder dr,":\\Projects\\ToddMiller\\ where dr is the user defined hard drive (the default is c). tum.growth=function(dr="c") { library(nlme) trnam=c("vehicle","EHT1864","Fulvestrant","EHT + Fulvestrant") da=read.csv(paste(dr,":\\Projects\\ToddMiller\\MCF-7_April_2016.csv",sep="")) da=da[1:202,] names(da)=c("week","id","tv","tr") da$tv=log(da$tv) par(mfrow=c(2,2),mar=c(4,4,3,1)) rse=matrix(ncol=2,nrow=4) ytv=c(100,200,400,700,1000);lytv=log(ytv) for(itr in 0:3) { dai=da[da$tr==itr,] uid=unique(dai$id);nuid=length(uid) plot(0:1,0:1,xlim=c(0,50),ylim=range(lytv),type="l",xlab="",ylab="",axes=F) mtext(side=1,"Week",line=2.5,cex=1.25);axis(side=1,seq(from=0,to=50,by=10)) mtext(side=2,"Tumor volume",line=2.5,cex=1.25);axis(side=2,lytv,labels=ytv)
print(paste("Dif synergy=",dif,", SEdif=",sqrt(vardif),", One-sided p-value=",pv)) text(30,log(800),paste("P-value synergy =",round(pnorm(-Z),4)),cex=1.5,font=2) } Below is the output of the call: 
Survival curves
The following R function computes survival curve assuming Bliss independence and computes the -value based on the logrank test using library survival (it must be installed before running this program). The call synergy.surv(job=1) produces Figure 7 and the call synergy.surv(job=3) produces Figure 8 . The survival times ni, niip, and ip are taken from Larkin et al. paper (2015) .
synergy.surv=function(job=1,dr="c") { #install.packages("survival") library(survival) if(job==1) #Larkin, Fig 1A Intention- to-Treat Population { ni=c (316, 292, 271, 177, 170, 160, 147, 136, 132, 124, 106, 86, 50, 38, 14, 9, 6 ,2,1,1,1,0) niip=c (314, 293, 275, 219, 208, 191, 173, 164, 163, 151, 137, 116, 65, 54, 18, 11, 7 ,2,1,0,0,0) ip=c (315, 285, 265, 137, 118, 95, 77, 68, 63, 54, 47, 42, 24, 17, 7, 4 ,3,0,0,0,0,0) ti=0:21 sni=ni/ni[1];sip=ip/ip[1];sniip=niip/niip[1] par(mfrow=c(1,1),mar=c(4,4,1,1)) matplot(ti,cbind(sni,sip,sniip),type="s",lty=1,lwd=3,col=c(2,3,4), xlab="",ylab="",axes=F) axis(side=1,0:21);axis(side=2,seq(from=0,to=1,by=.1),srt=90) sind=1-(1-sni)*(1-sip) lines(ti,sind,type="s",lwd=3) mtext(side=1,"Months",line=2.75,cex=1.5) mtext(side=2,"Progression-free survival, proportion",line=2.5,cex=1.5) legend(13,.9,c("Nivolumab","Ipilimumab","Nivolumab+ipilimumab","Drug independence"), cex=1.5,lty=1,col=c(2,3,4,1),lwd=3,bg="gray90") # Drug independence p-value 1,length(p.nii) ),rep(0,length(s.nii))))) names(da)=c("dyy","rec","tr") fl.surv survfit(Surv(dyy, rec)~tr, data = da) ss=survdiff(Surv(dyy, rec)~tr, data = da) pv=1-pchisq(ss [[5] ],df=1) text(0,.05,paste("Drugs independence p-value =",round(pv,2)),cex=1.5,adj=0,font=2) } if(job==2) #Larkin, Fig 1C Patients with PD-L1-Negative Tumors { ni=c (208,192,178,108,105,98,88,80,76,74,63,50,31,24,9,5,4,2,1,1,1,0) niip=c(210,195,181,142,134,123,112,106,105,96,88,79,42,36,13,9,6,2,1,0,0,0) ip=c (202, 183, 166, 82, 72, 59, 44, 39, 35, 26, 22, 12, 8, 3 ,1,0,0,0,0,0,0,0) #return(cbind(ni,niip,ip)) ti=0:21 sni=ni/ni[1];sip=ip/ip[1];sniip=niip/niip[1] par(mfrow=c(1,1),mar=c(4,4,1,1)) matplot (ti,cbind(sni,sip,sniip),type="s",lty=1,lwd=3,col=c(2,3,4) , xlab="",ylab="",axes=F) axis(side=1,0:21);axis(side=2,seq(from=0,to=1,by=.1),srt=90) legend(13,.9,c("Nivolumab","Ipilimumab","Nivolumab+ipilimumab","Drug independence"), cex=1.5,lty=1,col=c(2,3,4,1),lwd=3,bg="gray90") sind=1-(1-sni)*(1-sip) lines(ti,sind,type="s",lwd=3) mtext(side=1,"Months",line=2.75,cex=1.5) mtext(side=2,"Progression-free survival, proportion",line=2.5,cex=1. 1,length(p.nii) ),rep(0,length(s.nii))))) names(da)=c("dyy","rec","tr") fl.surv survfit(Surv(dyy, rec)~tr, data = da) ss=survdiff(Surv(dyy, rec)~tr, data = da) pv=1-pchisq(ss [[5] ],df=1) text(0,.05,paste("Drugs independence p-value =",round(pv,2)),cex=1.5,adj=0,font=2) } } Appendix. The two-drug copula and the R code 0.1. Mathematical derivation and properties of the two-drug copula mortality function Let two drugs  and  have their own singe-agent mortality functions   (ln   ) and   (ln   ) where   and   individual doses. To simplify the notation denote  = ln   and  = ln    The mortality function () as any cdf, must (1) be an increasing function, (2) vanish when  goes to −∞ and (3) approach 1 when  goes to +∞ For example, the popular Hill mortality function () = ( 50 )  (1 + ( 50 )  ) can be expressed on the log scale through the logit link, Demidenko (2017) . The two-agent mortality function  is built with the help of two probability concepts: the inverse normal cdf Φ −1 and the bivariate standard normal density with correlation coefficient  The function  which satisfies the properties formulated in the text, called the copula two-agent mortality function, is created as a double integral
is the bivariate standard normal density with the correlation coefficient  Property #2 follows from the fact that if   → 0 then  → −∞ and therefore   () → 0 which implies Φ −1 (  ()) → −∞ Thus the lower and the upper limits of the inner integral are −∞ and ∞ and integration turns the bivariate normal density into a marginal density,
The same proof works for drug  This means that the copula two-agent mortality function turns into a single-agent mortality function in the absence of the other drug.
Property #3 means that parameter  controls the drug interaction. When  = 0 two drugs act independently which means that function (1) turns into
the Bliss definition of independence. Indeed,
It is possible to prove that if   0 we have synergy and if   0 we have antagonism as stated in the property #3. Now we discuss numerical methods for computation our copula two-agent function. To facilitate computation (1) replace the lower finite limit of integration with the upper as follows:
and Leonov (2014). The technical difference is that our integration limit is lower and their integration limit is upper. The conceptual difference is that their model implies probabilistic independence when  = 0 i.e. the two-drug function collapses to the product of single-drug functions while our model results in Bliss independence.
There are several ways to compute the double integral appeared in (2). First, one can use an R function pmvnorm from the package mvtnorm. Second, the double integral can be reduced to a one-dimensional integral using the formula
where  = Φ 0 is the density of the standard normal cdf. Using this representation we express (2) as
One-dimensional integration is a built-in function in many computer languages. For example, in R it is integrate, and therefore special packages such as mvtnorm are not needed if the above formula is used.
Proof of Theorem. The single integral representation formula (4) is used for the proof, where  = ln   and  = ln   . (a) Without loss of generality we can assume that  ≥  so that   () ≥   () because we assume that   =    Then we need to prove that ( ; 1) =   () When  → 1 the denominator of the argument of the Φ function in (4) goes to zero and the numerator converges to Φ −1 (  ())− Therefore the argument of Φ converges to either −∞ or +∞ depending on the sign of Φ −1 (  ()) −  Since   () ≤   () we have Φ −1 (  ()) ≤ Φ −1 (  ()) Also we have  ≤ Φ −1 (  ()) since the right-hand side of this inequality is the upper limit of the integration. Combination of these two inequalities implies that the argument of function Φ converges to +∞ and therefore the integral converges to R Φ −1 (  ()) −∞ () = Φ(Φ −1 (  ())) =   () This means that in the limit ( ; 1) =   () +   () −   () =   (). (b) When  → −1 the argument of Φ converges to −∞ or +∞ depending on the sign of Φ −1 (  ()) +  where  ≤ Φ −1 (  ()) which implies that Φ −1 (  ()) +  ≤ Φ −1 (  ()) + Φ −1 (  ()) Consider the case when   ()+  () ≤ 05 Then both Φ −1 (  ()) and Φ −1 (  ()) are negative and therefore the argument of Φ in (4) converges to −∞ This means that in the limit ( ; −1) =   ()+  () The proof ( ; −1) = 1 when   () +   ()  1 is omitted.
Example: testing lethal effects of insecticides
Below we list the R code for estimation of the bivariate copula dose-response model using nonlinear least squares (nls function). It requires library mvtnorm (install "mvtnorm" first). The single dose-response probit models are be estimated using glm . See more detail in [2] .
#install.packages("mvtnorm") library(mvtnorm) # ab11=interc_rot,ab12=slope_rot,ab21=interc_pyr,ab22=slope_pyr aC=coef(oC) print(summary(oC))
